MedPath

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00000851
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To evaluate the safety and determine the pharmacokinetic disposition of stavudine (d4T) alone and in combination with didanosine (ddI), and whether concurrent administration alters the disposition of either drug. To compare d4T versus d4T plus ddI with respect to short and long term changes from baseline in plasma HIV RNA concentrations. To determine the relationship, if any, between drug exposure and viral burden.

In a pilot study of d4T and ddI given to eight children with advanced HIV for 24 weeks, the three children with baseline counts greater than 50 cells/micro liter experienced a 20% increase in their CD4+ lymphocyte counts. Based on these results, controlled trials of the same regimen for children with less advanced HIV disease should be undertaken.

Detailed Description

In a pilot study of d4T and ddI given to eight children with advanced HIV for 24 weeks, the three children with baseline counts greater than 50 cells/micro liter experienced a 20% increase in their CD4+ lymphocyte counts. Based on these results, controlled trials of the same regimen for children with less advanced HIV disease should be undertaken.

Eligible subjects receiving d4T will be assigned in an open manner to Arm 1, and subjects who have been receiving zidovudine (AZT) will be assigned in a randomized, double blind manner to Arms 2 and 3. Each subject will receive study drug for 48 weeks as follows: Arm 1 - d4T plus ddI, Arm 2 - d4T alone, Arm 3 - d4T plus ddI.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
198
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (35)

Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases

🇺🇸

Torrance, California, United States

Univ. of Colorado Denver NICHD CRS

🇺🇸

Aurora, Colorado, United States

Univ. of Connecticut Health Ctr., Dept. of Ped.

🇺🇸

Farmington, Connecticut, United States

Connecticut Children's Med. Ctr.

🇺🇸

Hartford, Connecticut, United States

Children's National Med. Ctr., ACTU

🇺🇸

Washington, District of Columbia, United States

Howard Univ. Washington DC NICHD CRS

🇺🇸

Washington, District of Columbia, United States

Univ. of Florida Jacksonville NICHD CRS

🇺🇸

Jacksonville, Florida, United States

Univ. of Miami Ped. Perinatal HIV/AIDS CRS

🇺🇸

Miami, Florida, United States

Cook County Hosp.

🇺🇸

Chicago, Illinois, United States

Chicago Children's CRS

🇺🇸

Chicago, Illinois, United States

Scroll for more (25 remaining)
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases
🇺🇸Torrance, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.